Annual or biannual mass drug administration in high-burden communities
School-age children primary target
Albendazole or mebendazole as platform drugs
Post-treatment monitoring
Stool O&P at 2 weeks post-treatment — up to 3 samples recommended
Confirm parasitological cure before discharge from follow-up
Patient Discharge Instructions
copy discharge instructions
Diagnosis and general information
Biliary ascariasis — roundworm migration into the bile ducts
Caused by Ascaris lumbricoides — a large intestinal roundworm
Worms migrate from the intestine into the liver bile ducts
Most cases resolve with medication and rest
Worms usually exit the bile ducts on their own within days to weeks
Follow-up ultrasound will confirm resolution
Medications at discharge
Take your prescribed anthelmintic (anti-worm) medication exactly as directed
Albendazole or mebendazole — take with food
Complete the full course even if feeling better
Pain and anti-spasm medications as prescribed
Take only as directed
Avoid NSAIDs if told to avoid them due to kidney or stomach concerns
Antibiotics if prescribed for infection
Complete the full course
Do not stop early even if feeling better
Diet and activity
Start with clear fluids and advance to low-fat foods as tolerated
Avoid fatty or spicy foods until fully recovered
Stay well hydrated
Rest for the first 24 to 48 hours after discharge
Gradually return to normal activities as pain improves
Food hygiene to prevent reinfection
Wash all raw vegetables and fruit thoroughly
Drink only safe treated water
Avoid contact with fecal-contaminated soil
Warning signs to return to the emergency department immediately
Return immediately for fever over 38.5 C with chills or rigors
May indicate bile duct infection spreading to blood
Return immediately for worsening or severe abdominal pain
Especially if the pain is constant rather than colicky
Return immediately for yellow skin or eyes getting worse
Worsening jaundice suggests worsening bile duct blockage
Return immediately for dark urine or pale stools developing
Signs of bile duct obstruction
Return immediately for vomiting that prevents taking medications
Or vomiting worms
Return immediately for confusion, extreme weakness, or low blood pressure symptoms
Dizziness or fainting on standing
Return if no improvement after 48 to 72 hours on treatment
May need further testing or endoscopic procedure
Follow-up plan
Ultrasound follow-up in 1 to 3 weeks to confirm worm has left bile ducts
Bring this discharge paperwork to your follow-up appointment
Stool test at 2 weeks after finishing anti-worm medication
Confirms the treatment worked
May require up to 3 stool samples tested
Treat household members and close contacts
Family members should be tested or treated for worms
Ask your doctor about treatment for household contacts
References
Guidelines and key sources
Primary literature
Khuroo MS, Rather AA, Khuroo NS, Khuroo MS — Hepatobiliary and Pancreatic Ascariasis — World Journal of Gastroenterology 2016 — PMID 27672273
Comprehensive review of hepatobiliary and pancreatic ascariasis
Epidemiology, clinical features, management
Khuroo MS, Zargar SA — Biliary Ascariasis, A Common Cause of Biliary and Pancreatic Disease in an Endemic Area — Gastroenterology 1985 — PMID 3965331
Landmark case series describing biliary ascariasis clinical syndromes
56% biliary colic, 15.2% recurrence rate at 4 years
Sandouk F, Haffar S, Zada MM, Graham DY, Anand BS — Pancreatic-Biliary Ascariasis, Experience of 300 Cases — American Journal of Gastroenterology 1997 — PMID 9399767
Large case series documenting risk factors and outcomes
Female sex 11.3 times higher odds ratio
Khuroo MS, Zargar SA, Mahajan R — Hepatobiliary and Pancreatic Ascariasis in India — Lancet 1990 — PMID 1972440
Ultrasound diagnostic criteria established
Sensitivity approximately 86% for biliary worms
Systematic reviews and guidelines
Conterno LO, Turchi MD, Correa I, Monteiro de Barros Almeida RA — Anthelmintic Drugs for Treating Ascariasis — Cochrane Database of Systematic Reviews 2020
Evidence base for albendazole and mebendazole efficacy
Global epidemiology and preventive chemotherapy strategies
WHO mass drug administration program evidence
Miller JM et al — Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases — IDSA and ASM 2024 Update — PMID ciae104
Stool ova and parasite testing recommendations
Kato-Katz technique for quantification
Supporting case series and imaging studies
González AH, Regalado VC, Van den Ende J — Non-Invasive Management of Ascaris Lumbricoides Biliary Tract Migration — Tropical Medicine and International Health 2001 — PMID 11286203
97% resolution with conservative management
Prospective study of 69 patients in Ecuador
Khuroo MS, Zargar SA, Mahajan R, Bhat RL, Javid G — Sonographic Appearances in Biliary Ascariasis — Gastroenterology 1987 — PMID 3297910
Inner tube sign and echogenic linear structure described
Ultrasound criteria for biliary ascariasis diagnosis
de Almeida BL et al — Biliary Ascariasis and Severe Bacterial Outcomes — International Journal of Infectious Diseases 2020 — PMID 32240824
Pediatric case series from Brazil
Severe bacterial complications including sepsis and hepatic abscess
Astudillo JA, Sporn E, Serrano B, Astudillo R — Ascariasis in the Hepatobiliary System, Laparoscopic Management — Journal of American College of Surgeons 2008 — PMID 18926454
Surgical management outcomes
Laparoscopic CBD exploration technique
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.